nodes	percent_of_prediction	percent_of_DWPC	metapath
Decamethonium—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0432	0.0432	CbGpPWpGaD
Decamethonium—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0429	0.0429	CbGpPWpGaD
Decamethonium—HRH3—Monoamine Transport—SLC6A4—conduct disorder	0.0393	0.0393	CbGpPWpGaD
Decamethonium—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0385	0.0385	CbGpPWpGaD
Decamethonium—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0383	0.0383	CbGpPWpGaD
Decamethonium—CHRNG—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0327	0.0327	CbGpPWpGaD
Decamethonium—CHRNE—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0308	0.0308	CbGpPWpGaD
Decamethonium—HRH3—Amine ligand-binding receptors—DRD4—conduct disorder	0.0303	0.0303	CbGpPWpGaD
Decamethonium—ACHE—Biogenic Amine Synthesis—COMT—conduct disorder	0.0261	0.0261	CbGpPWpGaD
Decamethonium—ACHE—Biogenic Amine Synthesis—MAOA—conduct disorder	0.0259	0.0259	CbGpPWpGaD
Decamethonium—CHRNG—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0246	0.0246	CbGpPWpGaD
Decamethonium—CHRNE—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0231	0.0231	CbGpPWpGaD
Decamethonium—HRH3—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0198	0.0198	CbGpPWpGaD
Decamethonium—CHRNG—Neuronal System—GABRA2—conduct disorder	0.0188	0.0188	CbGpPWpGaD
Decamethonium—ACHE—Monoamine Transport—SLC6A4—conduct disorder	0.0188	0.0188	CbGpPWpGaD
Decamethonium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0182	0.0182	CbGpPWpGaD
Decamethonium—CHRNE—Neuronal System—GABRA2—conduct disorder	0.0177	0.0177	CbGpPWpGaD
Decamethonium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0155	0.0155	CbGpPWpGaD
Decamethonium—ACHE—Melatonin metabolism and effects—MAOA—conduct disorder	0.0153	0.0153	CbGpPWpGaD
Decamethonium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0147	0.0147	CbGpPWpGaD
Decamethonium—ACHE—Peptide hormone metabolism—CGA—conduct disorder	0.0144	0.0144	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0137	0.0137	CbGpPWpGaD
Decamethonium—BCHE—Peptide hormone metabolism—CGA—conduct disorder	0.0129	0.0129	CbGpPWpGaD
Decamethonium—CHRNG—Transmission across Chemical Synapses—COMT—conduct disorder	0.0118	0.0118	CbGpPWpGaD
Decamethonium—CHRNG—Transmission across Chemical Synapses—MAOA—conduct disorder	0.0118	0.0118	CbGpPWpGaD
Decamethonium—CHRM2—Monoamine GPCRs—DRD4—conduct disorder	0.0117	0.0117	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0116	0.0116	CbGpPWpGaD
Decamethonium—CHRNE—Transmission across Chemical Synapses—COMT—conduct disorder	0.0111	0.0111	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.011	0.011	CbGpPWpGaD
Decamethonium—CHRNE—Transmission across Chemical Synapses—MAOA—conduct disorder	0.011	0.011	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0106	0.0106	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—GABRA2—conduct disorder	0.0105	0.0105	CbGpPWpGaD
Decamethonium—CHRM2—Amine ligand-binding receptors—DRD4—conduct disorder	0.00985	0.00985	CbGpPWpGaD
Decamethonium—CHRNG—Neuronal System—COMT—conduct disorder	0.00907	0.00907	CbGpPWpGaD
Decamethonium—CHRNG—Neuronal System—MAOA—conduct disorder	0.009	0.009	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—GABRA2—conduct disorder	0.00891	0.00891	CbGpPWpGaD
Decamethonium—CHRNE—Neuronal System—COMT—conduct disorder	0.00853	0.00853	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—GABRA2—conduct disorder	0.00846	0.00846	CbGpPWpGaD
Decamethonium—CHRNE—Neuronal System—MAOA—conduct disorder	0.00846	0.00846	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—CGA—conduct disorder	0.0081	0.0081	CbGpPWpGaD
Decamethonium—CHRM2—Monoamine GPCRs—HTR2A—conduct disorder	0.00764	0.00764	CbGpPWpGaD
Decamethonium—HRH3—G alpha (i) signalling events—DRD4—conduct disorder	0.0075	0.0075	CbGpPWpGaD
Decamethonium—HRH3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00696	0.00696	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00683	0.00683	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—COMT—conduct disorder	0.00658	0.00658	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00654	0.00654	CbGpPWpGaD
Decamethonium—CHRM2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00643	0.00643	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0061	0.0061	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00596	0.00596	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—COMT—conduct disorder	0.0056	0.0056	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00556	0.00556	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00532	0.00532	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00528	0.00528	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—GABRA2—conduct disorder	0.00524	0.00524	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Other—DRD4—conduct disorder	0.0052	0.0052	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—COMT—conduct disorder	0.00504	0.00504	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.00502	0.00502	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—MAOA—conduct disorder	0.00501	0.00501	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—GABRA2—conduct disorder	0.00467	0.00467	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—CGA—conduct disorder	0.00458	0.00458	CbGpPWpGaD
Decamethonium—HRH3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00454	0.00454	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—DRD4—conduct disorder	0.00454	0.00454	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—COMT—conduct disorder	0.00429	0.00429	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—MAOA—conduct disorder	0.00426	0.00426	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—CGA—conduct disorder	0.00416	0.00416	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—COMT—conduct disorder	0.00407	0.00407	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—MAOA—conduct disorder	0.00405	0.00405	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00389	0.00389	CbGpPWpGaD
Decamethonium—ACHE—ATF-2 transcription factor network—EP300—conduct disorder	0.00375	0.00375	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0036	0.0036	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00346	0.00346	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Other—HTR2A—conduct disorder	0.0034	0.0034	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—COMT—conduct disorder	0.00329	0.00329	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00327	0.00327	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00316	0.00316	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—HTR2A—conduct disorder	0.00296	0.00296	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—COMT—conduct disorder	0.00293	0.00293	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00291	0.00291	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00282	0.00282	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—CGA—conduct disorder	0.00273	0.00273	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00271	0.00271	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.00263	0.00263	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—DRD4—conduct disorder	0.00256	0.00256	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—COMT—conduct disorder	0.00252	0.00252	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—MAOA—conduct disorder	0.0025	0.0025	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CGA—conduct disorder	0.00246	0.00246	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.00244	0.00244	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—CGA—conduct disorder	0.00243	0.00243	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—DRD4—conduct disorder	0.00233	0.00233	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00226	0.00226	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—COMT—conduct disorder	0.00225	0.00225	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—MAOA—conduct disorder	0.00223	0.00223	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00221	0.00221	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—WASF1—conduct disorder	0.00197	0.00197	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00194	0.00194	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—HTR2A—conduct disorder	0.00167	0.00167	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—HTR2A—conduct disorder	0.00152	0.00152	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.00149	0.00149	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00148	0.00148	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.00148	0.00148	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00146	0.00146	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CGA—conduct disorder	0.00141	0.00141	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—DRD4—conduct disorder	0.00138	0.00138	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.00135	0.00135	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00126	0.00126	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CGA—conduct disorder	0.00125	0.00125	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00117	0.00117	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	0.000963	0.000963	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—HTR2A—conduct disorder	0.000898	0.000898	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	0.000834	0.000834	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CGA—conduct disorder	0.000799	0.000799	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—DRD4—conduct disorder	0.000757	0.000757	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—WASF1—conduct disorder	0.00064	0.00064	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—COMT—conduct disorder	0.000635	0.000635	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—MAOA—conduct disorder	0.00063	0.00063	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000611	0.000611	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—COMT—conduct disorder	0.000566	0.000566	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—MAOA—conduct disorder	0.000562	0.000562	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000545	0.000545	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	0.000544	0.000544	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	0.000494	0.000494	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—EP300—conduct disorder	0.000476	0.000476	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—DRD4—conduct disorder	0.000447	0.000447	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HTR2A—conduct disorder	0.000292	0.000292	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—EP300—conduct disorder	0.000272	0.000272	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—EP300—conduct disorder	0.000243	0.000243	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—EP300—conduct disorder	0.000155	0.000155	CbGpPWpGaD
